Focusing on the Healthcare Industry

With years of experience in investing in domestic and overseas healthcare companies, Bo Rongli has led investments in several enterprises such as ISR, TLA, and ONCIMMUNE. He possesses extensive expertise and resources in medical investment, incubation, and cross-border mergers and acquisitions.

Previously, he worked at Harvest Fund and served as a partner at Beijing Shengquan Investment Management Center (Limited Partnership). Currently, Mr. Bo is the Executive Director of Heracles and a partner at Heracles Investment. He also holds the position of Chairman at China Sweden Immunotherapy Co., Ltd.